???? ???????????? ?????????? ????? ??????? ??? ??? ??????????? ?????????? ??? ?????????? ???? ??????, ??? ????? ??????? ?? ?????????? ??? ?? ????? ?????. ??? ? ????????? ?????????, ? ????????? ??? ?? ??????? ???????????? in situ ?????????? ?? ???????? ???? ??? 35 ????, ?? ????? ??? ???????? 65% ??? ???? ???????????? ????? ?????? ???????? (Brindle et al. 1977), ??? ?? ??????? ??????? (??????? 25-64 ????) ?? ???????? 1980 ????????? ??????? 12% (Quinn et al. 1999).

????????? ??? ?? ??????? ??????? ?? ???????? ??? 1970 ?????? ?? 80% ?? ???????? ???? ??? 35 ????: ???????? ? ????????? ????????? ?????????? ?? ????????? ?????? ??????????? ??????????? (Adelstein 1981).

?? ??? ?????????? ??? ???????? ??? ??????? ??? ??? ??????? ??? ???????? ???? ??????, Albrow et al. (2012) ????????? ??? ?? ????????? ??????? ???? ??? ????????? 1970 ??? 1980 ??????????????? ?? ???????? ?????? ??? ?????????. ??????????? ?????? ?????? ???????????? «???? ???????» ??? ???????? ?? ???????? ??? ??????? ??? ????????? ??? ??? ?????? ????????? ??????? ??? ??? ??????? ??? ???????? (NHSCSP) ??? ???????? ?? 1988.

Quality control of all aspects of the screening programme is required, from taking the samples, screening and reporting the cytology, following up women with cytological abnormalities, and carrying out colposcopy, treatment of high-grade abnormalities and follow up after treatment (Arbyn et al. 2010).